Home
Login
Register
Live
Users
Tag cloud
Published News
Upcoming News
Submit a new story
World Pharma News Home
»
Blogs
»
Drug Injury Watch: FDA Warns Sandoz About Possible Quality-Control Problems At Its North Carolina Generic Drug Manufacturing Facility
->
Get all Published News delivered to your inbox!
(a free service delivered by FeedBurner)
3
Vote
Drug Injury Watch: FDA Warns Sandoz About Possible Quality-Control Problems At Its North Carolina Generic Drug Manufacturing Facility
Posted by
tjlpa
563 days ago
(
http://www.drug-injury.com
)
View profile
Category
:
Blogs
|
Tags
:
sandoz
generic-drugs
fda
drug-safety
Inspection Found Sandoz Failed To Properly Validate Manufacturing Process For Metoprolol Succinate ER Tablets (Generic Form Of Toprol XL) Before Distributing Pills
Discuss
Add this link to...
Bury
Add to:
|
Bookmarks
Comments
Who Voted
Related Links
Comments
Log in to comment
or register
here
.
Who voted for this story
worldpharmanews
G00gle
tjlpa
Related Links
Trial Date Set For SEROQUEL® Patent Litigation
Sandoz receives positive EU opinion for biosimilar filgrastim
Drug Injury Watch: Sandoz Metoprolol Succinate ER Tablets Recall Has Been Done Rather Quietly
Sandoz receives European Commission approval for biosimilar filgrastim
Sandoz to acquire EBEWE Pharma specialty generics business
What is World Pharma News?
World Pharma News .net is the first worldwide Web 2.0 pharmaceutical news service developed on the top of the World Pharma News .com Project.
Login
|
Register
Top Today
Published News
6
Randox Therapeutic Drug Monito...
5
How Electronic Medical Records...
6
Factors In Assessing Associati...
6
NEW Liquid quality control ser...
5
Case Report: Man Using Diabete...
Categories
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
Top Tags
apps
audio
buy cymbalta online kaufen
computer
create
drug-injury
fda
file
internet
pharma
read more
Comments